Bionano Genomics (BNGO)
(Real Time Quote from BATS)
$0.66 USD
-0.03 (-4.94%)
Updated Jun 25, 2024 10:20 AM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Brokerage Reports
Bionano Genomics, Inc. [BNGO]
Reports for Purchase
Showing records 21 - 37 ( 37 total )
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
4Q18 Recap - Strong Quarter and Runway Extended
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Model Update - Still Confident, but More Conservative
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
We are transferring lead coverage to Scott Henry due to the departure of the previous lead-covering analyst
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
Productive ASHG 2018, Several Posters on Saphyr and Two Announcements
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: Bionano Genomics, Inc.
Industry: Unclassified
MORNING - MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Bionano Genomics, Inc.
Industry: Medical - Biomedical and Genetics
We initiate coverage with a Buy rating and a $12.00/ share price target.
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D